Patient leaflet - Votrient
B. PACKAGE LEAFLET
Package leaflet: Information for the patient
Votrient 200 mg film-coated tablets
Votrient 400 mg film-coated tablets
pazopanib
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
-
– Keep this leaflet. You may need to read it again.
-
– If you have any further questions, ask your doctor or pharmacist.
-
– This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.
-
– If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What is in this leaflet
-
1. What Votrient is and what it is used for
-
2. What you need to know before you take Votrient
-
3. How to take Votrient
-
4. Possible side effects
-
5. How to store Votrient
-
6. Contents of the pack and other information
1. What Votrient is and what it is used for
Votrient is a type of medicine called a protein kinase inhibitor. It works by preventing the activity of proteins that are involved in the growth and spread of cancer cells.
Votrient is used in adults to treat:
-
- kidney cancer that is advanced or has spread to other organs.
-
- certain forms of soft-tissue sarcoma, which is a type of cancer that affects the supportive tissues
of the body. It can occur in muscles, blood vessels, fat tissue or other tissues that support, surround and protect the organs.
2. What you need to know before you take Votrient
Do not take Votrient
-
- if you are allergic to pazopanib or any of the other ingredients of this medicine (listed in
section 6).
Check with your doctor if you think this applies to you.
Warnings and precautions
Talk to your doctor before taking Votrient:
-
– if you have heart disease.
-
– if you have liver disease.
-
- if you have had heart failure or a heart attack.
-
- if you have had prior collapse of a lung.
-
– if you have had problems with bleeding, blood clots or narrowing of the arteries.
-
– if you have had stomach or bowel problems such as perforation (hole) or fistula (abnormal
passages forming between parts of the intestine).
-
- if you have thyroid problems.
-
- if you have problems with your kidney function.
-
- if you have or have had an aneurysm (enlargement and weakening of a blood vessel wall) or a
tear in a blood vessel wall.
Tell your doctor if any of these apply to you. Your doctor will decide whether Votrient is suitable for you. You may need extra tests to check that your kidneys, heart and liver are working properly.
High blood pressure and Votrient
Votrient can raise your blood pressure. Your blood pressure will be checked before you take Votrient and while you are taking it. If you have high blood pressure you will be treated with medicines to reduce it.
-
- Tell your doctor if you have high blood pressure.
If you are going to have an operation
Your doctor will stop Votrient at least 7 days before your operation as it may affect wound healing.
Your treatment will be restarted when the wound has adequately healed.
Conditions you need to look out for
Votrient can make some conditions worse or cause serious side effects. You must look out for certain symptoms while you are taking Votrient to reduce the risk of any problems. See section 4.
Children and adolescents
Votrient is not recommended for people aged under 18. It is not yet known how well it works in this age group. Moreover it should not be used in children younger than 2 years of age because of safety concerns.
Other medicines and Votrient
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes herbal medicines and other medicines you’ve bought without a prescription.
Some medicines may affect how Votrient works or make it more likely that you’ll have side effects.
Votrient can also affect how some other medicines work. These include:
-
– clarithromycin, ketoconazole, itraconazole, rifamicin, telithromycin, voriconazzole (used to
treat infection ).
-
– atazanavir, indinavir, nelfinavir, ritonavir, saquinavir (used to treat HIV ).
-
– nefazodone (used to treat depression ).
-
– simvastatin and possibly other statins (used to treat high cholesterol levels ).
-
– medicines that reduce stomach acid. The type of medicine that you are taking to reduce your
stomach acid (e.g. proton pump inhibitor, H2 antagonists or antacids) may affect how Votrient is taken. Please consult your doctor or nurse for advice.
Tell your doctor or pharmacist if you take any of these.
Votrient with food and drink
Don’t take Votrient with food , as it affects the way the medicine is absorbed. Take it at least two hours after a meal or one hour before a meal (see section 3).
Do not drink grapefruit juice while you are being treated with Votrient as this may increase the chance of side effects.
Pregnancy, breast-feeding and fertility
Votrient is not recommended if you are pregnant. The effect of Votrient during pregnancy is not known.
-
- Tell your doctor if you are pregnant or planning to get pregnant.
-
- Use a reliable method of contraception while you’re taking Votrient, and at least for 2 weeks
after, to prevent pregnancy.
-
- If you do become pregnant during treatment with Votrient, tell your doctor.
Don’t breast-feed while taking Votrient. It is not known whether the ingredients in Votrient pass into breast milk. Talk to your doctor about this.
Male patients (including those who have had vasectomies) who have partners who are either pregnant or who could become pregnant (including those who use other methods of contraception) should use condoms during sexual intercourse while taking Votrient and for at least 2 weeks after the last dose.
Fertility may be affected by treatment with Votrient. Talk to your doctor about this.
Driving and using machines
Votrient can have side effects that may affect your ability to drive or use machines.
-
- Avoid driving or using machines if you feel dizzy, tired or weak, or if your energy levels are
low.
Votrient contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially ‘sodium-free’.
3. How to take Votrient
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
How much to take
The usual dose is two Votrient 400 mg tablets (800 mg pazopanib) taken once a day. This is the maximum dose per day. Your doctor may need to reduce your dose if you get side effects.
When to take
Don’t take Votrient with food. Take it at least two hours after a meal, or one hour before a meal.
For example, you could take it two hours after breakfast or one hour before lunch. Take Votrient at about the same time each day.
Swallow the tablets whole with water, one after the other. Do not break or crush the tablets as this affects the way the medicine is absorbed and may increase the chance of side effects.
If you take more Votrient than you should
If you take too many tablets, contact a doctor or pharmacist for advice. If possible show them the pack, or this leaflet.
If you forget to take Votrient
Do not take a double dose to make up for a forgotten dose. Just take your next dose at the usual time.
Don’t stop Votrient without advice
Take Votrient for as long as your doctor recommends. Don’t stop unless your doctor advises you to.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Possible serious side effects
Swelling of the brain (reversible posterior leukoencephalopathy syndrome)
Votrient can, on rare occasions, cause swelling of the brain, which may be life threatening. Symptoms include:
-
- loss of speech
-
- change of vision
-
- seizure (fits)
-
- confusion
-
- high blood pressure
Stop taking Votrient and seek medical help immediately if you get any of these symptoms, or if you get headache accompanied with any of these symptoms.
Hypertensive crisis (sudden and severe rise in blood pressure)
Votrient can on occasion cause a sudden and severe rise in blood pressure. This is known as a hypertensive crisis. Your doctor will monitor your blood pressure while you are taking Votrient. Signs and symptoms of a hypertensive crisis may include: – severe chest pain
-
– severe headache
-
– blurred vision
-
– confusion
-
– nausea
-
– vomiting
-
– severe anxiety
-
– shortness of breath
-
– seizures (fits)
-
– fainting
Stop taking Votrient and seek medical help immediately if you develop hypertensive crisis.
Heart conditions
The risks of these problems may be higher for people with an existing heart problem, or who are taking other medicines. You will be checked for any heart problems while you are taking Votrient.
Cardiac dysfunction/heart failure, heart attack
Votrient can affect how well your heart pumps or can increase the likelihood of having a heart attack. Signs and symptoms include: – irregular or fast heartbeat
-
– rapid fluttering of your heart
-
– fainting
-
– chest pain or pressure
-
– pain in your arms, back, neck or jaw
-
– shortness of breath
-
– leg swelling
Seek medical help immediately if you get any of these symptoms.
Changes in heart rhythm (QT prolongation)
Votrient can affect heart rhythm which in some people can develop into a potentially serious heart condition known as torsade de pointes. This can result in a very fast heartbeat causing a sudden loss of consciousness.
Tell your doctor if you notice any unusual changes in your heart beat , such as beating too fast or too slow.
Stroke
Votrient can increase your likelihood of having a stroke. Signs and symptoms of stroke may include:
-
– numbness or weakness on one side of your body
-
– difficulty talking
-
– headache
-
– dizziness
Seek medical help immediately if you get any of these symptoms.
Bleeding
Votrient can cause severe bleeding in the digestive system (such as stomach, oesophagus, rectum or intestine), or the lungs, kidneys, mouth, vagina and brain, although this is uncommon. Symptoms include:
-
- passing blood in the stools or passing black stools
-
- passing blood in the urine
-
- stomach pain
-
- coughing or vomiting up blood
Seek medical help immediately if you get any of these symptoms.
Perforation and fistula
Votrient can cause a tear (perforation) in your stomach or intestinal wall or the development of an abnormal connection between two parts of your digestive tract (a fistula). Signs and symptoms may include: – severe stomach pain
-
– nausea and/or vomiting
-
– fever
-
– development of a hole (perforation) in the stomach, intestine or bowel from which bloody or
foul smelling pus is released
Seek medical help immediately if you get any of these symptoms.
Liver problems
Votrient can cause problems with your liver which may develop into serious conditions such as liver dysfunction and liver failure, which may be fatal. Your doctor will be checking your liver enzymes while you are taking Votrient. Signs that your liver may not be working properly may include: – yellowing of your skin or the whites of your eyes (jaundice)
-
– dark urine
-
– tiredness
-
– nausea
-
– vomiting
-
– loss of appetite
-
– pain on the right side of your stomach area (abdomen)
-
– bruising easily
Seek medical help immediately if you get any of these symptoms.
Blood clots
Deep vein thrombosis (DVT) and pulmonary embolism
Votrient may cause blood clots in your veins, especially in your legs (deep vein thrombosis or DVT), which may also travel to your lungs (pulmonary embolism). Signs and symptoms may include: – sharp chest pain
-
– shortness of breath
-
– rapid breathing
-
– leg pain
-
– swelling of your arms and hands or legs and feet
Thrombotic microangiopathy (TMA)
Votrient may cause blood clots in the small blood vessels in the kidneys and brain accompanied by a decrease in red blood cells and cells involved in clotting (thrombotic microangiopathy, TMA). Signs and symptoms may include: – bruising easily
-
– high blood pressure
-
– fever
-
– confusion
-
– drowsiness
-
– seizures (fits)
-
– decrease in urine output
Seek medical help immediately if you get any of these symptoms.
Tumour lysis syndrome
Votrient can cause a fast breakdown of cancer cells resulting in tumour lysis syndrome, which in some people may be fatal. Symptoms may include irregular heartbeat, seizures (fits), confusion, muscle cramps or spasms, or decrease in urine output. Seek medical help immediately if you get any of these symptoms.
Infections
Infections occurring while you take Votrient may possibly become serious. Symptoms of infections may include: – fever
-
– flu-like symptoms such as cough, tiredness and body aches that do not go away
-
– shortness of breath and/or wheezing
-
– pain while urinating
-
– cuts, scrapes or wounds that are red, warm, swollen or painful
Seek medical help immediately if you get any of these symptoms.
Lung inflammation
Votrient can, on rare occasions, cause lung inflammation (interstitial lung disease, pneumonitis), which in some people can be fatal. Symptoms include shortness of breath or cough that will not go away. You will be checked for any lung problems while you are taking Votrient.
Seek medical help immediately if you get any of these symptoms.
Thyroid problems
Votrient can lower the amount of thyroid hormone produced in your body. This can result in weight increase and tiredness. You will be checked for thyroid hormone levels while you are taking Votrient. Tell your doctor if you notice significant weight gain or tiredness.
Blurry or impaired vision
Votrient can cause separation or tear of the lining of the back part of the eye (retinal detachment or tear). This can result in blurry or impaired vision.
Tell your doctor if you notice any change in your vision.
Possible side effects (including possible serious side effects under the relevant frequency category).
Very common side effects ( may affect more than 1 in 10 people):
-
- high blood pressure
-
- diarrhoea
-
- feeling or being sick (nausea or vomiting)
-
- stomach pain
-
- loss of appetite
-
- weight loss
-
- taste disturbance or loss of taste
-
- sore mouth
-
- headache
-
- tumour pain
-
- lack of energy, feeling weak or tired
-
- changes in hair colour
-
- unusual hair loss or thinning
-
- loss of skin pigment
-
- skin rash, possibly involving peeling of the skin
-
- redness and swelling of the palms of the hands or soles of the feet
Tell your doctor or pharmacist if any of these side effects becomes troublesome.
Very common side effects that may show up in your blood or urine tests:
-
- increase in liver enzymes
-
- decrease in albumin in the blood
-
- protein in the urine
-
- decrease in the number of blood platelets (cells that help blood to clot)
-
- decrease in the number of white blood cells
Common side effects (may affect up to 1 in 10 people):
-
- indigestion, bloating, flatulence
-
- nose bleed
-
- dry mouth or mouth ulcers
-
- infections
-
- abnormal drowsiness
-
- difficulty sleeping
-
- chest pain, shortness of breath, leg pain, and swelling of the legs/feet. These could be signs of a
blood clot in your body (thromboembolism). If the clot breaks off, it may travel to your lungs and this may be life threatening or even fatal.
-
- heart becomes less effective at pumping blood around the body (cardiac dysfunction)
-
- slow heart beat
-
- bleeding in the mouth, rectum or lung
-
- dizziness
-
- blurred vision
-
- hot flushes
-
- swelling caused by fluid of face, hands, ankles, feet or eyelids
-
- tingling, weakness or numbness of the hands, arms, legs or feet
-
- skin disorders, redness, itching, dry skin
-
- nail disorders
-
- burning, prickling, itching or tingling skin sensation
-
- sensation of coldness, with shivering
-
- excessive sweating
-
- dehydration
-
- muscle, joint, tendon or chest pain, muscle spasms
-
- hoarseness
-
- shortness of breath
-
- cough
-
- coughing up blood
-
- hiccups
-
- collapsed lung with air trapped in the space between the lung and chest, often causing shortness
of breath (pneumothorax)
Tell your doctor or pharmacist if any of these effects become troublesome.
Common side effects that may show up in your blood or urine tests:
-
– underactive thyroid gland
-
– abnormal liver function
-
– increase in bilirubin (a substance produced by the liver)
-
– increase in lipase (an enzyme involved in digestion
-
– increase in creatinine (a substance produced in muscles)
-
– changes in the levels of other different chemicals / enzymes in the blood. Your doctor will
inform you of the results of the blood tests
Uncommon side effects (may affect up to 1 in 100 people):
-
- stroke
-
- temporary fall in blood supply to the brain (transient ischaemic attack)
-
- interruption of blood supply to part of the heart or heart attack (myocardial infarction)
-
- partial interruption of blood supply to part of the heart (myocardial ischaemia)
-
- blood clots accompanied by a decrease in red blood cells and cells involved in clotting
(thrombotic microangiopathy, TMA). These may harm organs such as the brain and kidneys.
-
- increase in the number of red blood cells
-
- sudden shortness of breath, especially when accompanied with sharp pain in the chest and /or
rapid breathing (pulmonary embolism)
-
- severe bleeding in the digestive system (such as stomach, oesophagus or intestine), or the
kidneys, vagina and brain
-
- heart rhythm disturbance (QT prolongation)
-
- hole (perforation) in stomach or intestine
-
- abnormal passages forming between parts of the intestine (fistula)
-
- heavy or irregular menstrual periods
-
- sudden sharp increase in blood pressure (hypertensive crisis)
-
- inflammation of the pancreas (pancreatitis)
-
- liver inflamed, not working well or damaged
-
- yellowing of the skin or whites of the eyes (jaundice)
-
- inflammation of the lining of the abdominal cavity (peritonitis)
-
- runny nose
-
- rashes which may be itchy or inflamed (flat or raised spots or blisters)
-
- frequent bowel movements
-
- increased sensitivity of the skin to sunlight
-
- decreased feeling or sensitivity, especially in the skin
-
- skin wound which does not heal (skin ulcer)
Rare side effects (may affect up to 1 in 1,000 people):
-
- inflammation of the lung ( pneumonitis)
-
- an enlargement and weakening of a blood vessel wall or a tear in a blood vessel wall
(aneurysms and artery dissections)
Not known (frequency cannot be estimated from the available data):
-
- tumour lysis syndrome resulting from a fast breakdown of cancer cells
-
- liver failure
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Votrient
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date (EXP) which is stated on the bottle and the carton. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Votrient contains
-
- The active substance is pazopanib (as hydrochloride).
Each Votrient 200 mg film-coated tablet contains 200 mg pazopanib.
Each Votrient 400 mg film-coated tablet contains 400 mg pazopanib.
-
- The other ingredients in the 200 mg and 400 mg tablets are: hypromellose, macrogol 400,
What Votrient looks like and contents of the pack
Votrient 200 mg film-coated tablets are capsule-shaped, pink with “GS JT” marked on one side. They are supplied in bottles of 30 or 90 tablets.
Votrient 400 mg film-coated tablets are capsule-shaped, white with “GS UHL” marked on one side.
They are supplied in bottles of 30 or 60 tablets.
Not all pack sizes or tablet strengths may be available in your country.
Marketing Authorisation Holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Lek Pharmaceuticals d.d.
Verovskova 57
1526 Ljubljana
Slovenia
Novartis Pharma GmbH
RoonstraBe 25
D-90429 Nuremberg
Germany
Glaxo Wellcome, S.A.
Avda. Extremadura, 3
09400 Aranda De Duero, Burgos
Spain
Novartis Farmacéutica S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | Lietuva SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Efc^rapufl Novartis Bulgaria EOOD Ten: +359 2 489 98 28 | Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 |
Česká republika Novartis s.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 88 04 52 555 |
Eesti SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
EÀÀàôa Novartis (Hellas) A.E.B.E. Tql: +30 210 281 17 12 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Polska Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Novartis Farma – Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italia Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Suomi/Finland Novartis Finland Oy Puh/Tel: +358 (0)10 6133 200 |
Kûnpoç
Novartis Pharma Services Inc.
Tql: +357 22 690 690
Sverige
Novartis Sverige AB
Tel: +46 8 732 32 00
Latvija
SIA Novartis Baltics
Tel: +371 67 887 070
United Kingdom (Northern Ireland)
Novartis Ireland Limited
Tel: +44 1276 698370
This leaflet was last revised in
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site:.
60